Skip to main content

Table 1 Partnerships formed by NMPA for the development of RS

From: Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications

 

Time

Collaborators

Collaborating research base

Key research areas

1

2013/09

Tianjin Binhai Food and Drug Administration and Tianjin Institute of Pharmaceutical Research

Tianjin Binhai Center for Food and Drug Regulatory Science Research

Drug and food technology and policy

2

2015/08

Peking University

Peking University Asia Pacific Economic Cooperation Regulatory Sciences Center of Excellence

Education and training, RS research and innovation, international collaboration, RS Information Technology and Policy

3

2016/12

Fudan University and University of Copenhagen

Sino-Danish Regulatory Science Center

Education and training, trainee exchange and professionals training RS program

4

2018/04

Tsinghua university

Institute of Regulatory Science and Chinese Medicine Research Institute

TCMs modernization and RS research

5

2019/04

Sichuan University

Medical Device Regulatory Science Research Base

RS in medical device

6

2019/06

Beijing University of Chinese Medicine

Chinese Medicine Regulatory Science Research Institute

RS in TCM

7

2019/06

China Academy of Chinese Medical Sciences

Chinese medicine Regulatory Science Research Center

RS in TCM

8

2019/10

Shenyang Pharmaceutical university

Drug Regulatory Science Research Base

Course development, Education and training, Research in RS

9

2019/12

Shandong university

Drug Regulatory Science Research Base

RS in pharmaceutical products

10

2019/12

South China University of Technology

Medical Device Regulatory Science Research Base

RS in medical device

11

2020/04

Shanxi Medical products Administration and Xi’an Jiaotong University

Northwest Institute of Pharmaceutical Regulatory Science

RS research, Training and Education